Literature DB >> 11161383

Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck.

J C Lang1, D E Schuller.   

Abstract

Differential gene expression between squamous cell carcinoma of the head and neck and matched normal tissue was studied by utilizing Representational Difference Analysis. Using this methodology, a novel gene, DESC1 was isolated. DESC1 possesses strong identity to the serine protease super-family. Comparison of DESC1 expression between primary squamous cell carcinoma and matched normal tissue shows that the level of DESC1 expression is reduced or absent in 11/12 SCC tissue specimens when compared to specimens of matched normal tissue. Tissue-specific expression studies further show that DESC1 expression can only be detected in tissues derived from the head and neck, and in skin, prostate and testes. Cell line studies demonstrate that DESC1 expression is epithelial-specific. Chromosomal localization studies indicate that DESC1 is located on the long arm of chromosome 4 at position q12-13. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161383      PMCID: PMC2363709          DOI: 10.1054/bjoc.2000.1586

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Efficient method for preparing normal and tumor tissue for RNA extraction.

Authors:  A W Gramza; J M Lucas; R E Mountain; D E Schuller; J C Lang
Journal:  Biotechniques       Date:  1995-02       Impact factor: 1.993

2.  Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.

Authors:  L Diatchenko; Y F Lau; A P Campbell; A Chenchik; F Moqadam; B Huang; S Lukyanov; K Lukyanov; N Gurskaya; E D Sverdlov; P D Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Genetic progression model for head and neck cancer: implications for field cancerization.

Authors:  J Califano; P van der Riet; W Westra; H Nawroz; G Clayman; S Piantadosi; R Corio; D Lee; B Greenberg; W Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

4.  Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.

Authors:  R Michalides; N van Veelen; A Hart; B Loftus; E Wientjens; A Balm
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

5.  Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes.

Authors:  O Loughran; L J Clark; J Bond; A Baker; I J Berry; K G Edington; I S Ly; R Simmons; R Haw; D M Black; R F Newbold; E K Parkinson
Journal:  Oncogene       Date:  1997-04-24       Impact factor: 9.867

6.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.

Authors:  A L Reed; J Califano; P Cairns; W H Westra; R M Jones; W Koch; S Ahrendt; Y Eby; D Sewell; H Nawroz; J Bartek; D Sidransky
Journal:  Cancer Res       Date:  1996-08-15       Impact factor: 12.701

7.  Frequent p53 mutations in head and neck cancer.

Authors:  K D Somers; M A Merrick; M E Lopez; L S Incognito; G L Schechter; G Casey
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

8.  Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.

Authors:  W Xia; Y K Lau; H Z Zhang; A R Liu; L Li; N Kiyokawa; G L Clayman; R L Katz; M C Hung
Journal:  Clin Cancer Res       Date:  1997-01       Impact factor: 12.531

9.  Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.

Authors:  J K Field; D A Spandidos; P M Stell; E D Vaughan; G I Evan; J P Moore
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

10.  Allelotype of head and neck squamous cell carcinoma.

Authors:  H Nawroz; P van der Riet; R H Hruban; W Koch; J M Ruppert; D Sidransky
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

View more
  17 in total

Review 1.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

2.  Serase-1B, a new splice variant of polyserase-1/TMPRSS9, activates urokinase-type plasminogen activator and the proteolytic activation is negatively regulated by glycosaminoglycans.

Authors:  Yuushi Okumura; Masaki Hayama; Etsuhisa Takahashi; Mieko Fujiuchi; Aki Shimabukuro; Mihiro Yano; Hiroshi Kido
Journal:  Biochem J       Date:  2006-12-15       Impact factor: 3.857

3.  Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.

Authors:  Siobhan L Webb; Andrew J Sanders; Malcolm D Mason; Wen G Jiang
Journal:  Mol Cell Biochem       Date:  2012-12-13       Impact factor: 3.396

4.  Mouse matriptase-2: identification, characterization and comparative mRNA expression analysis with mouse hepsin in adult and embryonic tissues.

Authors:  John D Hooper; Luisa Campagnolo; Goodarz Goodarzi; Tony N Truong; Heidi Stuhlmann; James P Quigley
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

Review 5.  Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.

Authors:  Andrew J Ramsay; John D Hooper; Alicia R Folgueras; Gloria Velasco; Carlos López-Otín
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

Review 6.  Cell surface-anchored serine proteases in cancer progression and metastasis.

Authors:  Carly E Martin; Karin List
Journal:  Cancer Metastasis Rev       Date:  2019-09       Impact factor: 9.264

7.  Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia?

Authors:  Laure Rittié; Trilokraj Tejasvi; Paul W Harms; Xianying Xing; Rajan P Nair; Johann E Gudjonsson; William R Swindell; James T Elder
Journal:  J Invest Dermatol       Date:  2016-06-14       Impact factor: 8.551

Review 8.  Membrane associated proteases and their inhibitors in tumour angiogenesis.

Authors:  A Noel; C Maillard; N Rocks; M Jost; V Chabottaux; N E Sounni; E Maquoi; D Cataldo; J M Foidart
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

9.  An investigation of the relationship between TMPRSS6 gene expression, genetic variants and clinical findings in breast cancer.

Authors:  Meltem Mete; Didem Can Trabulus; Canan Kelten Talu; Emre Ozoran; Tuba Mutlu; Bulent Tekin; Mehmet Guven
Journal:  Mol Biol Rep       Date:  2020-05-08       Impact factor: 2.316

10.  HDAC8 Activates AKT through Upregulating PLCB1 and Suppressing DESC1 Expression in MEK1/2 Inhibition-Resistant Cells.

Authors:  Soon-Duck Ha; Naomi Lewin; Shawn S C Li; Sung-Ouk Kim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.